Multidrug-Resistant Shiga ToxinProducing Escherichia coli O118:H16 in Latin America
To the Editor: We report the first isolation of a multiple antimicrobial drug-resistant strain of Shiga toxin-producing Escherichia coli (STEC) O118:H16 from cattle in Latin America. The strain was isolated during a study of (1) . Transmission of these pathogens from cattle to humans on farms was observed (5) .
Beginning in 1996, STEC O118:H16 has become important as an emerging pathogen in humans and has been associated with bloody diarrhea and hemolytic uremic syndrome (2) . Analysis of the antimicrobial resistance profiles showed that >96% of the European STEC O118:H16 strains showed resistance to one or more antimicrobial drugs in contrast to the 10% to 15% drug-resistant strains that were detected among STEC belonging to other serotypes (1,6,7). STEC O118:H16 showing multiresistance in up to eight different antimicrobial drugs predominated among younger isolates, indicating that drug resistance genes have accumulated over time in STEC O118:H16 strains. The frequency of antimicrobial drug resistance in STEC and Stx-negative E. coli in humans and animals was compared in a study by Schroeder et al. (8) . Among human clinical E. coli isolates, antimicrobial resistance was less frequently observed in STEC than in Stxnegative strains, whereas in cattle, antibiotic-resistant strains were found at similar frequencies in both groups of E. coli. The relatively higher frequency of antimicrobial-resistant STEC in cattle was explained by the use of antimicrobial drugs in cattle production, whereas human infections with STEC are generally not treated with antibiotics (8) . Cattle could thus be an important source of new emerging antibiotic-resistant STEC strains such as O118:H16.
The genetic basis of antimicrobial resistance in STEC O118:H16 is broad, including R-plasmids, integrons, transposons, and chromosomally inherited drug-resistance genes. Fluoroquinolone resistance has also been acquired by some STEC O118:H16 strains (1). The heterogenicity of antimicrobial drugresistance patterns, the increase of multidrug-resistant strains over time 
